Comparing two first-line diabetes pills for newly diagnosed type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares two diabetes pills, imeglimin and metformin, to see which one better improves how your cells process energy and lowers blood sugar in people recently diagnosed with type 2 diabetes. You would take one pill for the study period, and the goal is to find the most effective first treatment for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were diagnosed with type 2 diabetes within the last 12 months.
- Your HbA1c (a measure of average blood sugar) is between 6.5% and 7.5%.
- You have not taken any diabetes medication before, or you stopped any diabetes medication at least 3 months ago.
- Your kidney function is at least moderately good (eGFR 45 or higher).
- You are not pregnant, planning to become pregnant, or breastfeeding, and you do not have severe heart failure or heavy alcohol use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This study tests a new medication called TriGlytza-01 against the standard diabetes drug metformin. It is for adults with type 2 diabetes who are overweight or obese and whose blood sugar is not well controlled with metformin alone.
This trial tests a new combination pill (henagliflozin and metformin) compared to metformin alone in people recently diagnosed with type 2 diabetes. The goal is to see which treatment works better and is safer.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
Hear when a new Mitochondria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.